Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Feasibility Study of Temozolomide Maintenance Therapy in Elderly Patients with AML Following Induction Therapy with High Dose Mitoxantrone and High Dose Ara-C.

Doris Ponce, MD, Sreedhar Katragadda, MD, Delong Liu, MD.PhD, Muhammad Rasul, MD, Nasir Ahmed, MD, Tauseef Ahmed, MD, Karen Seiter, MD

Blood (2007) 110 (11): 4383.

https://doi.org/10.1182/blood.V110.11.4383.4383

Published: 2007

Journal Articles

Emerging Epidemics of Babesiosis in Hematology Consultation at a University Hospital.

Srilatha Hosur, MD, Delong Liu, MD, PHD, Karen Seiter, MD, John Nelson, MD, Maria Aguero-Rosenfeld, MD, Sergey Brodsky, MD, PHD, Tauseef Ahmed, MD, Gary Wormser, MD

Blood (2007) 110 (11): 3859.

https://doi.org/10.1182/blood.V110.11.3859.3859

Published: 2007

Journal Articles

Phase I Study of Temozolomide and Cisplatin in Patients with Acute Leukemia.

Sreedhar Katragadda, MD, Delong Liu, MD PhD, Dorota Halicka, PhD, Sanford Kempin, MD, Nasir Ahmed, MD, Tauseef Ahmed, MD, Karen Seiter, MD

Blood (2006) 108 (11): 4542.

https://doi.org/10.1182/blood.V108.11.4542.4542

Published: 2006

Journal Articles

Feasibility Study of Temozolomide Maintenance Therapy in Elderly Patients with AML Following Induction Therapy with High Dose Mitoxantrone and High Dose Ara-C.

Sreedhar Katragadda, MD, Muhammad Arshad, MD, Delong Liu, MD PhD, Nasir Ahmed, MD, Quihu Shi, PhD, Tauseef Ahmed, MD, Karen Seiter, MD

Blood (2006) 108 (11): 4546.

https://doi.org/10.1182/blood.V108.11.4546.4546

Published: 2006

Journal Articles

Phenyhexyl Isothiocyanate, a Novel Inhibitor of Histone Deacetylation and Methylation, Induce Growth Arrest and Apoptosis of Myeloma Cells.

Quanyi Lu, MD, PhD, Jane Feng, MD, Karen Seiter, MD, Tauseef Ahmed, MD, Dicky J.W. Chiao, PhD, Delong Liu, MD, PhD

Blood (2006) 108 (11): 5033.

https://doi.org/10.1182/blood.V108.11.5033.5033

Published: 2006

Journal Articles

High-Dose Mitoxantrone-Based Induction Therapy in Newly-Diagnosed AML. Results of 171 Patients Treated at NYMC between 1991–2003.

Karen Seiter, MD, Delong Liu, MD, PhD, Eric Feldman, MD, Qiuhu Shi, PhD, Paul Baskind, Muhammad Arshad, MD, Anila Qureshi, MD, Tauseef Ahmed, MD

Blood (2005) 106 (11): 1859.

https://doi.org/10.1182/blood.V106.11.1859.1859

Published: 2005

Journal Articles

Comparison of Two Induction Regimens, High Dose Cytarabine /Mitoxantrone vs Hyper-CVAD, for Adult Acute Lymphoblastic Leukemia/Lymphoma.

Woondong Jeong, MD, Delong Liu, MD, PhD, Sreedhar Katragadda, MD, Qiuhu Shi, Tauseef Ahmed, MD, Karen Seiter, MD

Blood (2005) 106 (11): 4589.

https://doi.org/10.1182/blood.V106.11.4589.4589

Published: 2005

Journal Articles

Phase II Study of Gemtuzumab Ozogamycin (GO) and Cytarabine (ARA-C) in Patients with High Risk MDS and AML..

Peter Kang, MD, Karen Seiter, MD, Delong Liu, MD, PhD, Muhammad Arshad, MD, Anila Qureshi, MD, John Nelson, MD, Tauseef Ahmed, MD

Blood (2004) 104 (11): 4723.

https://doi.org/10.1182/blood.V104.11.4723.4723

Published: 2004

Journal Articles

Valgancyclovir Significantly Reduced Reactivation of CMV Following Mini-Transplantation with MAP (Mitoxantrone, Ara-C, and Pentostatin) Regimen.

Anila Qureshi, MD, Karen Seiter, MD, Tauseef Ahmed, MD, John Nelson, MD, Delong Liu, MD, PhD

Blood (2004) 104 (11): 5082.

https://doi.org/10.1182/blood.V104.11.5082.5082

Published: 2004

NARROW

Feasibility Study of Temozolomide Maintenance Therapy in Elderly Patients with AML Following Induction Therapy with High Dose Mitoxantrone and High Dose Ara-C.

Emerging Epidemics of Babesiosis in Hematology Consultation at a University Hospital.

Phase I Study of Temozolomide and Cisplatin in Patients with Acute Leukemia.

Feasibility Study of Temozolomide Maintenance Therapy in Elderly Patients with AML Following Induction Therapy with High Dose Mitoxantrone and High Dose Ara-C.

Phenyhexyl Isothiocyanate, a Novel Inhibitor of Histone Deacetylation and Methylation, Induce Growth Arrest and Apoptosis of Myeloma Cells.

High-Dose Mitoxantrone-Based Induction Therapy in Newly-Diagnosed AML. Results of 171 Patients Treated at NYMC between 1991–2003.

Comparison of Two Induction Regimens, High Dose Cytarabine /Mitoxantrone vs Hyper-CVAD, for Adult Acute Lymphoblastic Leukemia/Lymphoma.

Phase II Study of Gemtuzumab Ozogamycin (GO) and Cytarabine (ARA-C) in Patients with High Risk MDS and AML..

Valgancyclovir Significantly Reduced Reactivation of CMV Following Mini-Transplantation with MAP (Mitoxantrone, Ara-C, and Pentostatin) Regimen.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only